The collaboration between Waukee APEX and Dr. Elitsa Ananieva aimed to raise awareness of bone and joint cancer in Iowa. The group analyzed cancer incidence and mortality rate data from the Iowa Cancer Registry from 1990-2013. The results showed that bone and joint cancer incidence rates in Iowa were higher than national rates, and that males in Iowa were about 20% more likely to have bone and joint cancer than females. Although rare, bone and joint cancer mortality rates in Iowa have remained steady over the years unlike other more common cancers.
World Cancer Day, established by the Union for International Cancer Control (UICC) in 2000, is observed every year on February 4th. Over 10 million people die each year from cancer, more than HIV/AIDS, malaria, and tuberculosis combined. This makes cancer a leading cause of death with a global impact; cancer is not specific to any one geographic region or any one demographic. Cancer can affect anyone of any age, but we are moving towards extraordinary medical breakthroughs in the fight against cancer...
World Cancer Day, established by the Union for International Cancer Control (UICC) in 2000, is observed every year on February 4th. Over 10 million people die each year from cancer, more than HIV/AIDS, malaria, and tuberculosis combined. This makes cancer a leading cause of death with a global impact; cancer is not specific to any one geographic region or any one demographic. Cancer can affect anyone of any age, but we are moving towards extraordinary medical breakthroughs in the fight against cancer...
Studies have shown that older women receive less aggressive screening and treatment for breast cancer. Geriatric Oncologist, Meghan Karuturi, of MD Anderson Cancer Center joins us in this webinar to discuss age bias and how it affects older patients.
US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)Innovara, Inc.
A presentation on cancer and ethnicity in the United States, and how the US can learn from other countries in regards to cancer control. - by Barri Blauvelt, CEO, Innovara, Inc.
Improving Breast Cancer outcomes in Communities of Color Steps Towards Equitybkling
Hayley Thompson, Ph.D., Faculty Director of the Office of Cancer Health Equity and Community Engagement at Karmanos Cancer Institute and leader of Population Studies and Disparities, gives an overview of recent efforts to improve health equity for women of color with breast cancer and make suggestions about how to make breast cancer outcomes more equitable.
This ground breaking program provided both survivors and health care professionals the opportunity to leverage each other's insights and an opportunity for all to hear "state-of-the-science" presentations on the epidemiology, pathogenesis, genomics and optimal multidisciplinary care of EAO-CRC.
The 2016 EAO CRC Summit featured keynote addresses from leading clinicians, epidemiologists and researchers from Europe, Africa, Australia and the nation's leading cancer centers and advocacy organizations.
An Interactive Discussion On Key Issues Affecting Young Adult Colorectal Cancer Patients and Their Caregivers
Powered By Our Survivor Community and Their Families
TAKE THE WHEEL: Healthy lifestyle changes that may reduce the risk of a colo...Fight Colorectal Cancer
Are you wondering what to do to reduce your chances that cancer may come back? Have you talked with your doctor about things you can do to prevent this?
Join us for this lifestyle webinar and gain information and insights on:
- How to eat healthy during treatment
- The best foods to eat after colon surgery
- Healthy lifestyle tips that may reduce your risk of a colorectal cancer recurrence.
Presented by Jessica Iannotta, MS, RD, CSO, CDN
Chief Operating Officer, Meals to Heal. Jessica is in charge of all operations including clinical and culinary operations ranging from menu development to evidence-based website content, relationships with registered dietitians and social workers and developing processes and protocols for intake, management and outcomes analysis of patients.
Studies have shown that older women receive less aggressive screening and treatment for breast cancer. Geriatric Oncologist, Meghan Karuturi, of MD Anderson Cancer Center joins us in this webinar to discuss age bias and how it affects older patients.
US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)Innovara, Inc.
A presentation on cancer and ethnicity in the United States, and how the US can learn from other countries in regards to cancer control. - by Barri Blauvelt, CEO, Innovara, Inc.
Improving Breast Cancer outcomes in Communities of Color Steps Towards Equitybkling
Hayley Thompson, Ph.D., Faculty Director of the Office of Cancer Health Equity and Community Engagement at Karmanos Cancer Institute and leader of Population Studies and Disparities, gives an overview of recent efforts to improve health equity for women of color with breast cancer and make suggestions about how to make breast cancer outcomes more equitable.
This ground breaking program provided both survivors and health care professionals the opportunity to leverage each other's insights and an opportunity for all to hear "state-of-the-science" presentations on the epidemiology, pathogenesis, genomics and optimal multidisciplinary care of EAO-CRC.
The 2016 EAO CRC Summit featured keynote addresses from leading clinicians, epidemiologists and researchers from Europe, Africa, Australia and the nation's leading cancer centers and advocacy organizations.
An Interactive Discussion On Key Issues Affecting Young Adult Colorectal Cancer Patients and Their Caregivers
Powered By Our Survivor Community and Their Families
TAKE THE WHEEL: Healthy lifestyle changes that may reduce the risk of a colo...Fight Colorectal Cancer
Are you wondering what to do to reduce your chances that cancer may come back? Have you talked with your doctor about things you can do to prevent this?
Join us for this lifestyle webinar and gain information and insights on:
- How to eat healthy during treatment
- The best foods to eat after colon surgery
- Healthy lifestyle tips that may reduce your risk of a colorectal cancer recurrence.
Presented by Jessica Iannotta, MS, RD, CSO, CDN
Chief Operating Officer, Meals to Heal. Jessica is in charge of all operations including clinical and culinary operations ranging from menu development to evidence-based website content, relationships with registered dietitians and social workers and developing processes and protocols for intake, management and outcomes analysis of patients.
We are all part of the effort in reducing bowel cancer. Apart from screening and early detection, risk can be actively reduced by making healthy lifestyle changes. There are more effective treatments being explored through research. Continual improvement in services for people affected by bowel cancer will also increase their chances of longer-term survival.
Hue Ump English Club Dec 09 Health OverviewBinhThang
This topic discused at Mortality,Morbidity in the Population and Sudden Infant Death Syndrome by Dr Professor Michael Dunne
QUT School of Public Health
Director, International Health Program.
Background: The incidence of cancers is increasing worldwide, particularly in the developing countries as shown by recent cancer stastics from the WHO. It is even anticipated that with the increase in life expentancy, consequent upon inproved standard of living and globalization, the burden of cancers will increase within this millenium. With respective to cancer of the prostate, it is the most common type of cancer in urology. In developing countries, diagnostic is done at a late stage of evolution. In Cameroon, data on prostate cancer are scanty whereas the incidence of this disease is increasing. Objective: This article is designed to describe the epidemiological features of prostate cancer at the General Hospital of Yaoundé. Patients and methods: A 4-year retrospective study of patients seen with the diagnosis of cancer at the Medical Oncology unit of the Yaoundé General Hospital between January 2012 and December 2015. The demographic pattern (age of patients, socio professional activity, marital status), clinical features (cancer diagnosis), treatment modalities and outcome were studied. Main results: Of the 7 775 patients enrolled in the Medical Oncology Service over the study period, 1.4% (n = 108) cases of prostate cancer were seen. The prevalence over the study period was 1.38% and a relatively large annual growth of cases with an annual average of 27 cases was noted. The average age of patients was 67.82 years with a range of 34-83 years. The commonest presenting symptoms were the urinary frequency (54.63%) whereas the least common were fatigue (05.5%) and straining (03.70%). PSA was obtained in 49 patients, representing about 45.4% of all patients. Only 14 (01.26%) had biopsy reports. Conclusion: Prostate cancer is a major problem facing the aging male, and inadequate facilities make early detection difficult. Therefore, treatment is mainly palliative because of late diagnosis.
This presents the trends, issues, and challenges in the Philippine Health Care Delivery System. The data were mostly taken from the Philippine Department of Health (DOH) website and DOH Region VI Office.
Inside you will find:
* 8 Australians a day saved from cancer: Over 61,000 Australian lives have been saved by improvements in cancer prevention, screening and greatment over the past 20 years
* CLEAR Study: What might happen next with the data we've collected
* Our achievements: The results of our cancer resarch over the past 20 years
* Annual resarch awards: New research projects that were awarded funding
* Join a Research Study - Make yourself available for research and help reduce the burden of cancer
APEX Bone Cancer DMU Symposium 2016-Final-11-21-16
1. Raising Awareness of Rare Cancers in Iowa:
Bone and Joint Cancer
Wachie Peters1, Mikayla Schnurr1, Haley Wood1, Holly Showalter1, and Elitsa Ananieva2
1Waukee APEX, Waukee High School, Waukee, IA; 2Des Moines University, Biochemistry Department, Des Moines, IA
Conclusion
Abstract
Methods
Results Results
Objectives
References
Introduction
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1990-1995 1996-2001 2002-2007 2008-2013
AgeAdjustedRate
Years
Male
Female
Bone and Joint Cancer in Iowa for the Period 1990-2013
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1990-1995 1996-2001 2002-2007 2008-2013
AgeAdjustedRate
Years
Male
Female
Mortality Rates
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
AgeAdjustedRates
Years
Incidence
Mortality
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
AgeAdjustedRates
Years
Incidence
Mortality
Females
Comparison of Incidence and Mortality Rates of Bone and Joint
Cancer in Iowa
Males
0
0.2
0.4
0.6
0.8
1
1.2
1.4
AgeAdjusted
Rates
Years
National rates
Iowa rates
Incidence
Mortality
Bone and Joint Cancer Incidence Rates in Iowa Over the Years
• Iowan males had higher incidence rates of bone and joint cancer than females between
1990-2013. The only exception was 2002-2007, when the male incidence rates dropped from
1.25 to 0.9 age adjusted rate.
• The female incidence rates of bone and joint cancer increased each year, with the incidence
rates being the lowest during 1990-1995 and the highest during 2008-2013.
• On average, Iowan males were 20% more likely to suffer from bone and joint cancer than
females.
Bone and Joint Cancer Mortality Rates in Iowa Over the Years
• The female mortality rates of bone and joint cancer remained consistent compared to the
male mortality rates which were always higher except for the years 2008-2013.
Bone and Joint Cancer in Males and Females in Iowa Over the Years
Males:
o Over the years, incidence rates showed larger fluctuations than mortality rates
with two increases (1996-1998, 2008-2010) and one dramatic decrease during
2002-2004.
Females:
o There were more fluctuations in the female incidence rates than mortality rates
over the years with two decreases (1993-1995, 1999-2001) followed by steady
rates of both incidence and mortality rates.
National vs. Iowa Rates of Bone and Joint Cancer Over the Years
• The incidence rates of bone and joint cancer in Iowa were for the most part higher than on
the National level
• The mortality rates of bone and joint cancer in Iowa were consistent with the National
mortality rates except for the years 2005-2007, where there was a slight increase in Iowa.
Comparison of Bone and Joint Cancer to Breast, Prostate, Colon, and Lung cancer Over
the Years
• The mortality rates of bone and joint cancer were very low in comparison to the mortality
rates recorded for breast, prostate, colon, and lung cancer in Iowa and on the National level.
However, the bone and joint cancer mortality rates remained steady while the mortality rates
of the 4 most common cancers decreased in the recent years.
• The survival rates for bone and joint cancer patients were lower than those for breast,
prostate, and colon cancer but higher than the lung cancer survival rates.
• Background information on bone cancer such as bone cancer types, different treatment options,
incidents and mortality rates were researched by using internet available recourses as cited in the
references (1-2).
• Bone cancer incidence and mortality rates for both males and females in Iowa were compared
using the age adjusted rate (AAR) from the years 1990-2013. Rates were per 100,000 population
and were age-adjusted by five-year age groups to the 2000 U.S. standard population based on
single years of age. Next, the AAR of the mortality and incidence rates of both males and females
were compared every three years in graphical form. The data of the AARs of Iowa were then
compared to National data.
• Mortality and survival cancer rates in Iowa were taken from the Iowa Cancer Registry and
compared to the National mortality and survival rates for the same types of cancers.
Waukee Aspiring Professional Experience (APEX), a program through Waukee High School
for students exploring health sciences while developing project management and
professional skills, has teamed up with Dr. Elitsa Ananieva to learn more about bone cancer.
The collaboration aimed at exploring bone and joint cancer in Iowa while raising awareness
about bone cancer to increase public involvement and research efforts devoted to bone
cancer patients. The Iowa Cancer Registry was used to search incidence and mortality rates
of bone and joint cancer between the years of 1990-2013 and to compare bone and joint
cancer to the four most common cancers in Iowa: breast, prostate, colon, and lung cancer.
Next, the surveillance, epidemiology, and end results program (SEER) administered by the
National Cancer Institute was used to compare incidence and mortality rates of bone and
joint cancer on the national level. Our results showed that Iowan males were around 20%
more likely to suffer from bone and joint cancer than females. In comparison to the four most
common cancers, bone and joint cancer mortality rates were very low but remained
consistent over the years. In contrast, breast, prostate, and colon cancer mortality rates
decreased in the recent years reflecting the increased prevention care and research efforts
devoted to these cancers. In conclusion, although rare, bone and joint cancer in Iowa has
higher prevalence than on national level, is more common in males, and the survival rates
for bone cancer patients are lower than those for breast, prostate, or colon cancer.
Rare cancers receive disproportionately lower
public attention because they affect a small
population. As a result, less research funding
and clinical trials are undertaken to address
rare cancers. A cancer diagnosis is devastating
for every cancer patient regardless of how
common the cancer type. The research we
conducted was on bone and joint cancer in
Iowa. This was performed to support Dr.
Ananieva’s long term goal of understanding the
cellular processes of bone cancer.
Years 1990-1995 1996-2001 2002-2007 2008-2013
Male 0.42 0.54 0.51 0.35
Female 0.38 0.34 0.4 0.39
Years 1990-1995 1996-2001 2002-2007 2008-2013
Male 1.05 1.25 0.90 1.23
Female 0.78 0.88 0.98 0.96
• Raise scientific and public awareness for Bone and Joint cancer.
• Demonstrate critical thinking, communication, creativity, and collaboration by gaining positive
feedback from conference attendees.
• Show understanding of how Bone cancer has impacted the population of Iowa by comparing data
collected from 1990-2013.
• Compare National Bone cancer rates to Iowa Bone cancer rates.
Year
1990-
1992
1993-
1995
1996-
1998
1999-
2001
2002-
2004
2005-
2007
2008-
2010
2011-
2013
Incidence 1.05 1.06 1.41 1.1 0.69 1.1 1.36 1.1
Mortality 0.5 0.33 0.56 0.51 0.41 0.61 0.39 0.46
Year
1990-
1992
1993-
1995
1996-
1998
1999-
2001
2002-
2004
2005-
2007
2008-
2010
2011-
2013
Incidence 0.95 0.6 1.09 0.67 0.96 1.01 1 0.92
Mortality 0.37 0.39 0.27 0.42 0.21 0.58 0.46 0.31
Incidence Rates
Comparison of Bone, Breast, Prostate, Colon, and Lung Cancer,
1990-2013
Bone and Joint Cancer
1990-2013 Females (F) Males (M)
Population at Risk in Iowa 35887229 34626840
Total New Cases 345 394
Total Deaths 173 176
New Cases (Age-Adjusted Rates) 0.9 1.11
Deaths (Age-Adjusted Rates) 0.4 0.5
Percent Survival 56% 55.0%
New Cases (Percent difference F/M) 19% less than M
Deaths (Percent difference F/M) 20% less than M
Average Bone and Joint Cancer in Iowan Females and Males
for the Period 1990-2013
0
20
40
60
80
100
Percentage(%)
Years
Bone and Joint cancer
Breast cancer
Prostate cancer
Colon cancer
Lung cancer
0
20
40
60
80
100
Percentage(%)
Years
Iowa Cancer Survival USA Cancer Survival
0
10
20
30
40
50
60
AgeAdjustedRates
Breast cancer
Prostate cancer
Colon cancer
Lung cancer
Bone and Joint cancer
0
10
20
30
40
50
60
1990
1993
1996
1999
2002
2005
2008
2011
AgeAdjustedrates
Years
Iowa Cancer Mortality USA Cancer Mortality
1. Iowa Cancer Registry
http://www.cancer-rates.info/ia/
2. SEER Stat Fact Sheets for bone, breast, colon, prostate and lung cancer:
2.1 https://seer.cancer.gov/statfacts/html/bones.html
2.2 https://seer.cancer.gov/statfacts/html/breast.htm
2.3 https://seer.cancer.gov/statfacts/html/colorect.html
2.4 https://seer.cancer.gov/statfacts/html/prost.html
2.5 https://seer.cancer.gov/statfacts/html/lungb.html